Introduction
The bispecific antibodies market is on a remarkable growth trajectory, fueled by advancements in biotechnology, increasing investment in research and development, and a rising demand for novel therapeutic options in oncology and other diseases. Bispecific antibodies (BsAbs) are engineered proteins that can simultaneously bind to two different antigens, offering a unique mechanism...
English
Français
Español
Português
Deutsch
Türkçe
Dutch
Italiano
Russian
Romaian